CINECA IRIS Institutional Research Information System

FORNAI, MATTEO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 16.227
AS - Asia 7.384
EU - Europa 6.661
SA - Sud America 1.051
Continente sconosciuto - Info sul continente non disponibili 720
AF - Africa 386
OC - Oceania 30
Totale 32.459
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 15.784
IT - Italia 2.673
SG - Singapore 2.373
CN - Cina 2.002
HK - Hong Kong 1.134
SE - Svezia 877
BR - Brasile 869
VN - Vietnam 603
DE - Germania 595
BG - Bulgaria 432
GB - Regno Unito 391
FI - Finlandia 325
CA - Canada 296
TR - Turchia 291
FR - Francia 288
RU - Federazione Russa 269
AT - Austria 210
IN - India 206
JP - Giappone 173
UA - Ucraina 157
CI - Costa d'Avorio 148
KR - Corea 126
NL - Olanda 118
PL - Polonia 78
MX - Messico 77
CH - Svizzera 75
AR - Argentina 70
IQ - Iraq 64
BD - Bangladesh 60
PK - Pakistan 60
SN - Senegal 48
BE - Belgio 45
UZ - Uzbekistan 39
ZA - Sudafrica 39
NG - Nigeria 37
ID - Indonesia 36
SA - Arabia Saudita 28
ES - Italia 27
IR - Iran 27
MA - Marocco 27
EC - Ecuador 26
VE - Venezuela 26
PH - Filippine 24
AU - Australia 23
CO - Colombia 20
EG - Egitto 19
KE - Kenya 15
AZ - Azerbaigian 14
CZ - Repubblica Ceca 14
MY - Malesia 14
PY - Paraguay 14
AE - Emirati Arabi Uniti 13
LT - Lituania 13
TW - Taiwan 13
JM - Giamaica 12
JO - Giordania 12
TN - Tunisia 12
DZ - Algeria 11
CL - Cile 10
IE - Irlanda 10
PT - Portogallo 10
CR - Costa Rica 9
NO - Norvegia 9
AL - Albania 8
HN - Honduras 8
IL - Israele 8
KZ - Kazakistan 8
LB - Libano 8
OM - Oman 8
PA - Panama 8
UY - Uruguay 8
BJ - Benin 7
GR - Grecia 6
HU - Ungheria 6
KG - Kirghizistan 6
NZ - Nuova Zelanda 6
PE - Perù 6
PS - Palestinian Territory 6
RO - Romania 6
TT - Trinidad e Tobago 6
ET - Etiopia 5
NP - Nepal 5
SV - El Salvador 5
DO - Repubblica Dominicana 4
GD - Grenada 4
GH - Ghana 4
LV - Lettonia 4
NI - Nicaragua 4
QA - Qatar 4
RS - Serbia 4
AO - Angola 3
BS - Bahamas 3
BY - Bielorussia 3
CG - Congo 3
DK - Danimarca 3
EU - Europa 3
GE - Georgia 3
GT - Guatemala 3
TH - Thailandia 3
XK - ???statistics.table.value.countryCode.XK??? 3
Totale 31.712
Salva come PNG Salva come JPEG
Città #
Ashburn 1.605
Singapore 1.307
Woodbridge 1.125
Fairfield 1.107
Hong Kong 1.100
Dallas 976
Ann Arbor 959
San Jose 908
Houston 874
Chandler 821
Santa Clara 799
Milan 513
Seattle 440
Sofia 427
Wilmington 426
Shanghai 420
Beijing 410
Cambridge 388
Serra 382
New York 319
Boardman 263
Council Bluffs 262
Los Angeles 232
Ottawa 200
Princeton 184
Jacksonville 166
Lawrence 160
Pisa 158
Lauterbourg 152
Abidjan 148
Izmir 147
Vienna 146
Tokyo 144
Florence 140
Medford 139
Hefei 133
Helsinki 124
Munich 123
Ho Chi Minh City 120
Rome 114
Dong Ket 112
Nanjing 108
Des Moines 105
Seoul 104
Hanoi 103
London 101
Chicago 95
Istanbul 86
Buffalo 85
Frankfurt am Main 83
São Paulo 78
Bremen 75
Redondo Beach 74
Atlanta 63
Dearborn 62
Nanchang 56
Turku 54
Lucca 53
Dakar 48
Warsaw 47
Lancaster 46
Columbus 45
Lappeenranta 45
The Dalles 44
Ogden 43
Brussels 42
Falls Church 42
San Diego 41
Bern 40
Redwood City 37
Tashkent 35
Nuremberg 34
Lagos 33
Phoenix 33
Washington 33
Chennai 32
Naples 32
Orem 31
Pune 30
Jüchen 29
Montreal 29
Zurich 29
Marseille 28
Toronto 28
Montignoso 27
Hebei 26
Boulder 25
Brooklyn 25
Tianjin 25
Kunming 24
Rio de Janeiro 24
Amsterdam 23
Guangzhou 23
Livorno 23
Belo Horizonte 22
Fuzhou 22
Baghdad 20
Changsha 20
Kent 20
Manchester 20
Totale 21.383
Salva come PNG Salva come JPEG
Nome #
Derivati isoindolici come attivatori di AMPK 540
Preparation of isoindoline derivatives for use as AMPK activators 347
An integrated assessment of histopathological changes of the enteric neuromuscular compartment in experimental colitis. 306
Dietary Supplement, Containing the Dry Extract of Curcumin, Emblica and Cassia, Counteracts Intestinal Inflammation and Enteric Dysmotility Associated with Obesity 303
Protective effects of Saccharomyces boulardii CNCM I-745 Against Nonsteroidal anti-inflammatory drug-induced intestinal injury 299
Telogen effluvium following bivalent human papilloma virus vaccine administration: a report of two cases 295
Exploiting the Pyrazolo[3,4-d]pyrimidin-4-one ring system as a useful template to obtain potent adenosine deaminase inhibitors, 273
Protective Role of Flavonoids Against Colonic Motor Dysfunctions Associated with High Fat Diet-Induced Obesity 273
Characterization of mechanisms underlying the effects of esomeprazole on the impairment of gastric ulcer healing with addition of NSAID treatment 270
COMPOSTI INIBITORI DELL’INFLAMMASOMA NLRP3 E LORO USO 269
Enteric glial NLRP3 inflammasome contributes to gut mucosal barrier alterations in a mouse model of diet-induced obesity 265
Quality of adverse drug reaction (QADRA) reports: an algorithm to appraise the efficiency of spontaneous reporting systems in pharmacovigilance 251
Derivati benzofuranici come attivatori di AMPK 251
Anti-inflammatory effect of a novel adenosine deaminase inhibitor in experimental colitis 235
Colonic dysmotility associated with high-fat diet-induced obesity: Role of enteric glia 233
Pathophysiology of NSAID-associated intestinal lesions in the rat: Luminal bacteria and mucosal inflammation as targets for prevention 230
Assessment of serum cytokines predicts clinical and endoscopic outcomes to vedolizumab in ulcerative colitis patients 229
Neuropsychiatric adverse events associated with statins: epidemiology, pathophysiology, prevention and management 227
A Comparative Study on the Efficacy of NLRP3 Inflammasome Signaling Inhibitors in a Pre-clinical Model of Bowel Inflammation 226
Palmitoylethanolamide Counteracts Enteric Inflammation and Bowel Motor Dysfunctions in a Mouse Model of Alzheimer’s Disease 222
Microbiota-gut-brain axis in health and disease: Is NLRP3 inflammasome at the crossroads of microbiota-gut-brain communications? 221
Evaluation of the beneficial effects of a GABA-based product containing Melissa officinalis on post-inflammatory irritable bowel syndrome: a preclinical study 219
Dietary Supplementation with the Probiotic SF68 Reinforces Intestinal Epithelial Barrier in Obese Mice by Improving Butyrate Bioavailability 218
Prodromal Intestinal Events in Alzheimer's Disease (AD): Colonic Dysmotility and Inflammation Are Associated with Enteric AD-Related Protein Deposition 217
Colonic motor dysfunctions in a mouse model of high-fat diet-induced obesity: an involvement of A2B adenosine receptors 216
Emerging role of Cyclooxygenase isoforms in the control of gastrointestinal neuromuscular functions 213
A2a receptors mediate inhibitory effects of adenosine on colonic motility in the presence of experimental colitis 211
Constitutive expression of cyclooxygenase-2 in the neuromuscular compartment of normal human colon 210
The flavonoid compound apigenin prevents colonic inflammation and motor dysfunctions associated with high fat diet-induced obesity 209
Small bowel protection against NSAID-injury in rats: Effect of rifaximin, a poorly absorbed, GI targeted, antibiotic 208
Resistance artery mechanics and composition in angiotensin II-infused mice: effects of cyclooxygenase-1 inhibition 207
Preclinical development of fa5, a novel amp-activated protein kinase (Ampk) activator as an innovative drug for the management of bowel inflammation 206
The pharmacological blockade of P2X4 receptor as a viable approach to manage visceral pain in a rat model of colitis 205
Adenosine signaling as target in cardiovascular pharmacology 204
Neonatal Adaptation Issues After Maternal Exposure to Prescription Drugs: Withdrawal Syndromes and Residual Pharmacological Effects 204
A1 and A2a receptors mediate inhibitory rffects of adenosine on the motor activity of human colon 202
Inducible Nitric Oxide Synthase is involved in endothelial dysfunction of mesenteric small arteries from hypothyroid rats 202
NLRP3 at the crossroads between immune/inflammatory responses and enteric neuroplastic remodelling in a mouse model of diet-induced obesity 201
Role of coxibs in the strategies for gastrointestinal protection in patients requiring chronic non-steroidal anti-inflammatory therapy 200
Influence of the serotonin transporter 5HTTLPR polymorphism on symptom severity in irritable bowel syndrome 200
Safety of MF-59 adjuvanted vaccine for pandemic influenza: results of the vaccination campaign in an Italian health district 199
Cyclooxygenase inhibitors modulate pro-fibrotic signalling mediated by TGFbeta in experimental colitis 194
Clinical efficacy of esomeprazole in the prevention and healing of digestive toxicity associated with non-steroidal anti-inflammatory drugs in elderly patients 194
NSAID-induced enteropathy: are the currently available selective COX-2 inhibitors all the same? 194
Neuromodulation of colonic motility by cycloxygenase isoforms in the presence of experimental bowel inflammation 193
Efficay and tolerability of meloxicam, a COX-2 preferential nonsteroidal anti-inflammatory drug: a review 193
Enteric protective effects of the combination Bifidobacterium longum and lactoferrin in a rat model of diclofenac-induced intestinal injury. 193
Luteolin Prevents Cardiometabolic Alterations and Vascular Dysfunction in Mice With HFD-Induced Obesity 191
Use of Saccharomyces boulardii CNCM I-745 as therapeutic strategy for prevention of nonsteroidal anti-inflammatory drug-induced intestinal injury 188
AMPK Activators as Novel Drug Candidates for the Treatment of Inflammatory Bowel Diseases 187
Glial A2B Adenosine Receptors Modulate Abnormal Tachykininergic Responses and Prevent Enteric Inflammation Associated with High Fat Diet-Induced Obesity 187
Role of A2a adenosine in the regulation of colonic motility in normal human colon 186
Genetics and pharmacogenetics of aminergic transmitter pathways in functional gastrointestinal disorders 186
Adverse reactions to oncologic drugs: spontaneous reporting and signal detection 186
Alteration of colonic excitatory tachykininergic motility and enteric inflammation following dopaminergic nigrostriatal neurodegeneration 185
The AMPK enzyme-complex: from the regulation of cellular energy homeostasis to a possible new molecular target in the management of chronic inflammatory disorders 185
Effects of pantoprazole on ulcer healing delay associated with NSAID treatment 184
Evaluation of cytokine levels as putative biomarkers to predict the pharmacological response to biologic therapy in inflammatory bowel diseases 183
Preparation of benzofuran derivatives for use as AMPK activators 182
Expression pattern of COX isoforms in experimental models of enteric and airway inflammation 181
Genetic polymorphisms of thiopurine S-methyltransferase in a cohort of patients with systemic autoimmune diseases 181
Canonical and Non-Canonical Activation of NLRP3 Inflammasome at the Crossroad between Immune Tolerance and Intestinal Inflammation 181
Serum oncostatin M at baseline predicts mucosal healing in Crohn's disease patients treated with infliximab 181
Donepezil improves vascular function in a mouse model of Alzheimer's disease 181
Cyclooxygenase-1 is involved in endothelial dysfunction of mesenteric small arteries from angiotensin II-infused mice 180
Response to Endothelial nitric oxide synthase, cyclooxygenase-2, and essential hypertension: is there an interaction? 180
Endothelial dysfunction in small arteries of essential hypertensive patients: role of cyclooxygenase-2 in oxidative stress generation 180
Enteric α-synuclein impairs intestinal epithelial barrier through caspase-1-inflammasome signaling in Parkinson’s disease before brain pathology 180
Differential role of cyclooxygenase 1 and 2 isoforms in the modulation of colonic neuromuscular function in experimental inflammation 179
Clinical evaluation of piroxicam-FDDF and azithromycin in the prevention of complications associated with impacted lower third molar extraction 179
Interplay between colonic inflammation and tachykininergic pathways in the onset of colonic dysmotility in a mouse model of diet-induced obesity 179
Mechanisms underlying the non-anticoagulant effects of apixaban and dabigatran on the integrity of intestinal mucosa: a comparative pre-clinical study. 178
Protective effects of the combination Bifidobacterium longum plus lactoferrin against NSAID-induced enteropathy 178
Intestinal histomorphological and molecular alterations in patients with Parkinson's disease 176
Effects of esomeprazole on healing of non-steroidal anti-inflammatory drug (NSAID)-induced gastric ulcers in the presence of a continued NSAID treatment: characterization of molecular mechanisms 176
Effects of selective cyclooxygenase-2 inhibitors on healing of experimental gastric ulcers and mucosal expression of cyclooxygenase isoforms 175
Reduced modulating actions of adenosine pathways on enteric neuromuscular activity in experimental colitis 175
Allopurinol adherence among patients with gout: an Italian general practice database study 175
Effects of selective cyclooxygenase-2 inhibitors on healing of experimental gastric ulcers and mucosal expression of cyclooxygenase isoforms 173
Control of enteric neuromuscular functions by purinergic A3 receptors in normal rat distal colon and experimental bowel inflammation 173
High Levels of β-Amyloid, Tau, and Phospho-Tau in Red Blood Cells as Biomarkers of Neuropathology in Senescence-Accelerated Mouse 173
Involvement of the P2X7 purinergic receptor in colonic motor dysfunction associated with bowel inflammation in rats 172
The intestinal barrier in disorders of the central nervous system 171
Lansoprazole prevents experimental gastric injury induced by non-steroidal anti-inflammatory drugs through a reduction of mucosal oxidative damage 171
Differential role of A1 and A2a purinergic receptors in the control of colonic neurumuscular function in the presence of experimental colitis 170
Safety concerns associated with the use of serotonin reuptake inhibitors and other serotonergic/noradrenergic antidepressants during pregnancy: a review 169
Managing Obesity and Related Comorbidities: A Potential Pharmacological Target in the Adenosine System? 169
The role of purinergic pathways in the pathophysiology of gut diseases: pharmacological modulation and potential therapeutic applications 168
Switching off CD73: a way to boost the activity of conventional and targeted antineoplastic therapies 168
Intestinal dysfunction in Parkinson's disease: Lessons learned from translational studies and experimental models 167
Role of cyclooxygenase isoforms in the altered excitatory motor pathways of human colon with diverticular disease 167
Enteric Glia and Brain Astroglia: Complex Communication in Health and Disease along the Gut-Brain Axis 165
Adenosine deaminase in the modulation of immune system and its potential as a novel target for treatment of inflammatory disorders 163
Adenosine and inflammation: what's new on the horizon? 163
Transient acute liver failure complicating transurethral resection syndrome 163
The blockade of adenosine deaminase ameliorates chronic experimental colitis through the recruitment of adenosine A2A and A3 receptors 161
Deepening the Mechanisms of Visceral Pain Persistence: An Evaluation of the Gut-Spinal Cord Relationship 160
NSAID activated gene (NAG-1) plays a role in the impairing effects of cyclooxygenase inhibitors on gastric ulcer repair 158
Mild hypothyroidism anticipates and accelerates age-related endothelial dysfunction in rat mesenteric small arteries: role of inducibile NO synthase 157
Enteric dysfunctions in experimental Parkinson's disease: alterations of excitatory cholinergic neurotransmission regulating colonic motility in rats 157
Totale 20.360
Salva come PNG Salva come JPEG
Categoria #
all - tutte 94.893
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 94.893
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.957 0 97 62 114 377 282 79 118 109 79 138 502
2022/20232.877 314 380 206 287 292 362 32 234 500 49 189 32
2023/20242.504 243 251 298 196 380 405 59 108 104 93 123 244
2024/20256.578 76 245 106 404 574 722 602 304 694 865 687 1.299
2025/20268.086 533 852 1.033 634 837 651 1.267 409 537 796 283 254
2026/20271.165 499 666 0 0 0 0 0 0 0 0 0 0
Totale 32.459